Paige Teter, PA-C

Dr. Tomei is board eligible in neurosurgery. Her special interests include congenital spinal disorders and spina bifida, craniosynostosis, pediatric brain tumors, traumatic brain injury in children and Chiari malformations. She was named to the UH Cleveland Medical Center staff in 2014.

Edward Burney, MD is an esteemed ophthalmologist based in Cleveland, Ohio, specializing in cataract and lens implant surgery, comprehensive ophthalmology, eye exams, and glaucoma treatment. As the Director of Anterior Segment Diseases and Surgery Center at UH Cleveland Medical Center, Dr. Burney brings a wealth of experience and expertise to his practice. With a background that includes training at prestigious institutions such as the Johns Hopkins Hospital, University Hospitals Of Cleveland, and Case Western Reserve University School Of Medicine, Dr. Burney has garnered a reputation for excellence in patient care and surgical proficiency. His dedication to his field is reflected in his numerous accolades, including being named among the Best Doctors in America consistently since 1996. Dr. Burney's commitment to providing top-notch ophthalmic care is further demonstrated through his leadership role at the Cleveland VA Medical Center, where he has overseen significant growth in facilities and services. Patients value his thoroughness, clear communication, and compassionate approach, as evidenced by the overwhelmingly positive reviews he has received for his exceptional care. Generated from the website content

Amanda L. Amin, MD, MS, FACS, FSSO, is a native of the Chicagoland area. In 2021, Dr. Amin joined UH Cleveland Medical Center in the role of Section Chief of Breast Surgery in the Division of Surgical Oncology, as well as Co-Director of the Breast Cancer Program for UH Seidman Cancer Center. Board certified in general surgery, Dr. Amin is a fellow of the American College of Surgeons and the Society of Surgical Oncology. Dr. Amin is dedicated to improving existing and developing new therapies for the management of high-risk and malignant breast disease through pioneering research. She is particularly interested in opportunities for de-escalation of surgical intervention for atypical ductal hyperplasia and ductal carcinoma in situ.